Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam

LONDON--(BUSINESS WIRE)-- Regulatory News: BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces that: All resolutions proposed at its Extraordinary General Meeting held today (the “EGM”) were duly passed with overwhelming support (over 95% in favour). Effective immediately, BenevolentAI has merged into Osaka Holdings S.à r.l. (“Osaka Holdings”). As a result, the original BenevolentAI entity has ceased to exist. Simultaneously, Osaka Holdings has converted its legal form from an S.à r.l. to an S.A., and has adop...

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

LONDON--(BUSINESS WIRE)-- Regulatory News: BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces: Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure. Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads. ...

Hardman & Co Monthly: January 2025

Feature article: Hardman & Co Healthcare Index, 2024 – Tough year for Life Sciences By Dr Martin Hall The main function of the HHI is to monitor the performance, and to highlight the attractiveness, of life sciences investments over the long term, and to try to identify those stocks that have disruptive technologies that consistently allow them to outperform both the index and the markets. Many of the 53 constituents of the index are high-risk, with micro-capitalisations and a long way from profitability. Despite this, some companies can still make extremely attractive returns for investors. ...

Bekaert : 2025 guidance at risk, Neutral maintained

Atos : Un plan stratégique offensif mais qui ne laisse pas entrevoir de catalyseurs à court terme

Maisons du Monde : Q1 2025 revenue down sharply by 10.9%, in line with expectations. Cumulative FCF target of €100 million in four years vs three years initially